Abstract 53: Prediabetes Status Modifies the Effect of a DASH-Patterned Grocery Intervention on Cardiometabolic Risk Including Glycemic Control in Black Adults with High Blood Pressure

Y Yingfei Wu (BIDMC, Boston, Massachusetts, United States) H Hannah Col (BIDMC, Harvard Medical School, Boston, Massachusetts, United States) R Roger Davis K Kenneth Mukamal (BIDMC-Harvard Medical School, Boston, Massachusetts, United States) J Jennifer Cluett (BIDMC-Harvard Medical School, Boston, Massachusetts, United States) S Stephanie Fitzpatrick (Northwell Health, New York, New York, United States) K Kristen Kraemer (BIDMC-Harvard Medical School, Boston, Massachusetts, United States) E Emily Aidoo (BIDMC, Boston, Massachusetts, United States) M Marian Budu (Beth Israel Deaconess Medical Ctr., Boston, Massachusetts, United States) F Fredrick Larbi (Beth Israel Deaconess Medical Ctr, Boston, Massachusetts, United States) K Kayla Ferro (BIDMC, Boston, Massachusetts, United States) D Dhrumil Patil R Ruth-Alma Turkson-Ocran (Ohio State University, Columbus, Ohio, United States) S Stephen Juraschek (BIDMC-Harvard Medical School, Boston, Massachusetts, United States)

Abstract

Introduction: The Dietary Approaches to Stop Hypertension (DASH) diet was designed for its cardiovascular benefits but emphasizes higher carbohydrates. Its impact on glycemia in adults with impaired glycemic control is not well-characterized. Hypothesis: A DASH-patterned grocery intervention will lower hemoglobin A1c (HbA1c) among adults with prediabetes. Methods: GoFresh randomized Black adults with high blood pressure (BP) (systolic BP 120 to <150 mmHg, diastolic BP <100 mmHg) living in urban food deserts around Boston, Massachusetts to 3 months of weekly delivered DASH-patterned groceries or three $500 stipends every 4 weeks for self-directed grocery shopping. HbA1c was measured at baseline and 3-months after the intervention phase. The primary outcome of this post-hoc analysis was the difference in 3-month difference in HbA1c between study groups by baseline prediabetes status (HbA1c ≥5.7%). Effects were modeled via generalized estimating equations with a three-way interaction term for time, study group, and prediabetes status. Secondary outcomes included changes in BP, body mass index, serum lipids, and urinary albumin-creatinine ratio. Results: Among 180 participants, 61 (34%) had HbA1c≥5.7% at baseline ( Table 1 ). The effect of the intervention on differences in HbA1c was significantly different between those with and without prediabetes ( P -interaction=0.006) ( Figure 1 ). Among those with prediabetes, HbA1c changed by -0.08% (95%CI -0.14, -0.02) for the intervention group and by 0.04% (95%CI -0.02, 0.11) for the control group (difference-in-difference [DiD] -0.12%; 95%CI -0.21, -0.03). Among those without prediabetes, there was no significant difference in HbA1c changes between intervention groups (DiD 0.05%; 95%CI -0.01, 0.12). Similarly, the effect of the intervention on triglycerides was greater in the prediabetes group (difference-in-DiD: -0.32 log[mg/dL]; 95%CI -0.53, -0.12; P -interaction=0.002) ( Table 2 ). No interaction effects were observed for other cardiometabolic markers. Conclusion: Beyond improving BP, providing DASH-patterned groceries significantly improved glycemia and triglyceride levels among Black adults with high BP and prediabetes. These results suggest that the GoFresh grocery ordering guidelines may be especially useful to improve cardiometabolic health among populations at higher risk for diabetes. Future work should evaluate whether this strategy can mitigate progression to diabetes among those with impaired glycemic control.

Article Details

Journal Circulation
Volume / Issue Vol. 153, Issue Suppl_1
Published March 24, 2026
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (14)

Y

Yingfei Wu

BIDMC, Boston, Massachusetts, United States

H

Hannah Col

BIDMC, Harvard Medical School, Boston, Massachusetts, United States

R

Roger Davis

K

Kenneth Mukamal

BIDMC-Harvard Medical School, Boston, Massachusetts, United States

J

Jennifer Cluett

BIDMC-Harvard Medical School, Boston, Massachusetts, United States

S

Stephanie Fitzpatrick

Northwell Health, New York, New York, United States

K

Kristen Kraemer

BIDMC-Harvard Medical School, Boston, Massachusetts, United States

E

Emily Aidoo

BIDMC, Boston, Massachusetts, United States

M

Marian Budu

Beth Israel Deaconess Medical Ctr., Boston, Massachusetts, United States

F

Fredrick Larbi

Beth Israel Deaconess Medical Ctr, Boston, Massachusetts, United States

K

Kayla Ferro

BIDMC, Boston, Massachusetts, United States

D

Dhrumil Patil

R

Ruth-Alma Turkson-Ocran

Ohio State University, Columbus, Ohio, United States

S

Stephen Juraschek

BIDMC-Harvard Medical School, Boston, Massachusetts, United States